Related Experiment Videos
Rhinitis medicamentosa.
J T Ramey1, E Bailen, R F Lockey
1Division of Allergy & Clinical Immunology, University of South Florida & James A. Haley VA Medical Center, Tampa, Florida 33612, USA. jtramey@yahoo.com
Summary
Rhinitis medicamentosa (RM), or rebound congestion, results from overuse of nasal decongestants and other medications. Treatment involves stopping the offending agent, potentially with intranasal glucocorticosteroids.
Area of Science:
- Otolaryngology
- Pharmacology
Background:
- Rhinitis medicamentosa (RM) is nasal congestion caused by medication overuse.
- It can also result from non-decongestant medications like antihypertensives.
- Current knowledge relies heavily on case reports and histology due to limited prospective studies.
Purpose of the Study:
- To review the causes, mechanisms, and histological findings of rhinitis medicamentosa.
- To discuss diagnostic challenges and treatment strategies for RM.
Main Methods:
- Review of existing literature, including case reports and histological studies.
- Analysis of mechanisms of drug-induced nasal congestion.
Main Results:
- Histological changes in RM include nasociliary loss, squamous cell metaplasia, and epithelial changes.
- The exact dose or duration for RM development is undetermined.
- Different mechanisms cause congestion with topical vs. oral medications.
Conclusions:
- Overuse of nasal decongestants is a primary cause of RM.
- Validated diagnostic criteria for RM are needed.
- Discontinuation of the causative agent is the primary treatment, with intranasal glucocorticosteroids as an adjunct.